phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with thromboxane b2 in 1 studies
| Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 191 | 4 | 23 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattaneo, M; Falcon, CR; Ghidoni, A; Mannucci, PM | 1 |
1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and thromboxane b2
| Article | Year |
|---|---|
The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionized calcium.
Topics: Adult; Amino Acid Chloromethyl Ketones; Anticoagulants; Antithrombins; Blood Platelets; Calcium; Citrates; Citric Acid; Diabetes Mellitus; Humans; In Vitro Techniques; Middle Aged; Platelet Count; Thromboxane B2 | 1993 |